Clinical Trial Update: Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 repeat-dose food-effect study of the investigational compound GSK256073F in healthy adult subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• GSK256073F

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dyslipidaemias | Phase 1 | Status: COMPLETED